EDESA BIOTECH, INC. Revenue from Contract with Customer, Including Assessed Tax
EDESA BIOTECH, INC. (EDSA) reported Revenue from Contract with Customer, Including Assessed Tax of $0 for the 12-month period ending 2018-09-30, per its 10-K filed 2018-11-30.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2018-11-30
- EDESA BIOTECH, INC. revenue from contract with customer, including assessed tax for the quarter ending 2018-09-30 was $0.00.
- EDESA BIOTECH, INC. revenue from contract with customer, including assessed tax for the quarter ending 2018-06-30 was $0.00.
- EDESA BIOTECH, INC. revenue from contract with customer, including assessed tax for the quarter ending 2017-09-30 was $0.00.
- EDESA BIOTECH, INC. revenue from contract with customer, including assessed tax for the quarter ending 2017-06-30 was $0.00.
- EDESA BIOTECH, INC. revenue from contract with customer, including assessed tax for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- EDESA BIOTECH, INC. revenue from contract with customer, including assessed tax for fiscal 2017 was $50.00K.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $0.00 derived: sum of 2 quarters · filed 2018-11-30 | $0.00 10-K · filed 2018-11-30 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | ||
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $0.00 derived: sum of 2 quarters · filed 2018-11-30 | $50.00K 10-K · filed 2018-11-30 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-08 | $50.00K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |